iBio, Inc. (IBIO) stock
IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.75+0.04 (+5.86%)
Close on Nov 17, 2026Market cap $48.11MP/E –Yield –
iBio cash
Cash and short-term investments held at the end of each period.
iBio's cash was $76.65M at Sep 30, 2026. For fiscal 2026 it was $88.04M, up 901.4% from the year before. Over ten years it grew 18.6% a year on average. The highest annual figure on record is $88.04M in fiscal 2026.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $88.04M | +901.4% |
| FY2025 | Jun 30, 2025 | $8.79M | -39.1% |
| FY2024 | Jun 30, 2024 | $14.43M | +90.3% |
| FY2023 | Jun 30, 2023 | $7.58M | -73.6% |
| FY2022 | Jun 30, 2022 | $28.67M | -63.0% |
| FY2021 | Jun 30, 2021 | $77.40M | +40.4% |
| FY2020 | Jun 30, 2020 | $55.11M | +1146.6% |
| FY2019 | Jun 30, 2019 | $4.42M | 0.0% |
| FY2018 | Jun 30, 2018 | $4.42M | -72.3% |
| FY2017 | Jun 30, 2017 | $15.93M | 0.0% |
| FY2016 | Jun 30, 2016 | $15.93M | +67.8% |
| FY2015 | Jun 30, 2015 | $9.49M | +164.5% |
| FY2014 | Jun 30, 2014 | $3.59M | -18.7% |
| FY2013 | Jun 30, 2013 | $4.41M | -21.5% |
| FY2012 | Jun 30, 2012 | $5.62M | +97.8% |
| FY2011 | Jun 30, 2011 | $2.84M | +212.4% |
| FY2010 | Jun 30, 2010 | $909.93K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $76.65M | +53.9% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $88.04M | +901.4% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $74.82M | +1343.8% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $52.69M | +627.9% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $49.81M | +342.3% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $8.79M | -39.1% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $5.18M | -19.4% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $7.24M | +78.3% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $11.26M | +136.5% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $14.43M | +90.3% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $6.43M | -34.5% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $4.06M | +2.8% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $4.76M | -70.0% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $7.58M | -73.6% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $9.82M | -75.3% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $3.95M | -91.3% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $15.88M | -79.5% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $28.67M | -66.1% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $39.71M | -56.5% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $45.15M | -41.8% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $77.40M | +40.4% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $84.63M | +742.9% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $91.25M | +2409.0% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $77.54M | +3587.3% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $55.11M | +1146.6% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $10.04M | +11.1% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $3.64M | -72.8% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $2.10M | -74.2% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $4.42M | 0.0% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $9.04M | +166.0% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $13.36M | +82.8% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $8.16M | +38.0% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $4.42M | -72.3% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $3.40M | -72.6% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $7.31M | -55.2% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $5.92M | -70.6% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $15.93M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $12.42M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $16.33M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $20.10M | – |
See a number that looks wrong?